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2 Abstract
2.1 Aims
The aim was to explore familial aggregation of diabetes in genetically related and unrelated individuals.
2.2 Methods
We included citizens from Danish nationwide registries between 1995-2018 and calculated rate ratios (RR) of 
diabetes based on family relation using Poisson regression. 
2.3 Results 
Of 7.3 million individuals eligible for inclusion, we identified 343,237 (4.7%) with diabetes. The RR of diabetes was 
2.02 (95% CI: 1.99–2.05; p<0.0001) if any relative had diabetes, 1.79 (95% CI: 1.76–1.83) if a father had diabetes, and 
2.06 (95% CI: 2.02–2.10) if a mother had diabetes. If both parents had diabetes, the RR was 3.40 (95% CI: 3.24–3.56). 
Among full siblings, the RR for developing diabetes was 2.77 (95% CI: 2.71–2.84) and 5.76 (95% CI: 5.00–6.63) for 
twins. For second-degree relatives, half siblings with a common mother had a RR of 2.35 (95% CI: 2.15–2.56), and 
with a common father 1.99 (95% CI: 1.81–2.17). Furthermore, the RR was 1.60 (95% CI: 1.56–1.64) if a wife had 
diabetes, and 1.41 (95% CI: 1.38–1.44) if a husband had diabetes. A subgroup analysis of individuals receiving insulin 
only treatment (N=23,054) demonstrated a similar risk pattern, although with slightly higher risk estimates.
2.4 Conclusions/interpretation
Family aggregation of diabetes is associated with genetic disposition with maternal status being the predominant 
factor. Furthermore, we observed increased risk of diabetes in second-degree relatives, and between unrelated 
spouses, indicating that environmental factors influence diabetes risk substantially.                                                                                                                                                                                     
2.5 Keywords
Diabetes, heredity, epidemiology, genetic factors, environmental factors
2.6 Abbreviations
Aside from the standard abbreviations in Diabetologia (http://www.diabetologia-
journal.org/webpages/styleguide/abbreviations.html) no abbreviations were used.
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3 Introduction
There has been a massive global increase in type 2 diabetes along with a small but surprising rise in type 1 diabetes 
[1,2]. While diabetes is reaching pandemic status, the familial contribution to the development of diabetes is not 
well understood and to what extent it derives from shared genetics versus environment. Previous studies have 
found that the risk of type 2 diabetes is at least two times higher in individuals with one parent with diabetes and up 
to four times higher with two parents with diabetes [3,4]. Furthermore, the concordance rate of type 2 diabetes has 
been shown to be higher in monozygotic versus dizygotic twins [5–7]. Despite these associations, efforts to 
determine a clear genetic cause of type 2 diabetes have been troublesome. Genome-wide association studies have 
led to the identification of more than 100 genetic loci, each tied to a small but increased susceptibility of developing 
type 2 diabetes [8]. However, this polygenic understanding of type 2 diabetes captures only up to 10 percent of 
familial aggregation of the disease [9]. Furthermore, even among groups with a genetically increased risk of 
diabetes, environmental factors play a key role for diabetes development, as exemplified by the Mexican Pima 
Indians, among who there is less than one-fifth of the type 2 diabetes prevalence compared to Pima Indians in the 
Unites States[10]. Additionally, multivariable modelling has shown that lifestyle and genetic factors predict 
development of type 2 diabetes with similarly high accuracy [11].  In contrast, almost half of the familial aggregation 
in type 1 diabetes can be ascribed to known loci [12]. However, hereditability in type 1 diabetes is less distinct as 
more than 90 percent of patients with type 1 diabetes does not have a first-degree relative with the disease. 
Nonetheless, the lifelong risk of type 1 diabetes has been found to be significantly increased in those who have a 
relative with type 1 diabetes compared to having no family history, and the concordance rate among identical twins 
is approximately 50 percent [5,13]. 
It is unclear to which extent this familial aggregation is based on genetics and which part is environment. To further 
detangle this, we performed a study on familial aggregation of diabetes in Denmark including both related and 
unrelated individuals.
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4 Methods
4.1 Study population
In Denmark, all citizens are at birth assigned a unique and permanent personal identification number (civil 
registration number) that is used throughout all private and public sectors to identify individuals. All healthcare and 
governmental institutions as well as pharmacies are required by law to register data on individuals using the civil 
registration number, enabling direct linkage of various registries and data sources containing anonymized data.
The present study included patients with new-onset diabetes from January 1, 1995 to December 31, 2018 and their 
family relations, as listed in the Danish nationwide registries. Specifically, we used a combination of data on drug 
prescriptions (The Danish National Prescription Registry [14]) , causes of death (The Danish registers of causes of 
death [15]), immigration and family relations (The Danish Civil Registration System [16])  to calculate the risk of 
developing diabetes based on paternal, maternal, sibling, half-sibling, and marital status. Individuals who were 
adopted or had incomplete immigration data were excluded.
4.2 Definition of diabetes 
Diabetes was defined by the claim of at least two prescriptions of a glucose-lowering drug (Anatomical Therapeutic 
Chemical Classification (ATC) A10), starting from the day of the last prescription in the first quarter (90 days) with at 
least two prescriptions. 
To ensure that only individuals with new-onset diabetes were included, anyone claiming a prescription of a glucose-
lowering drugs within the first study year January 1, 1995 to December 31, 1995) was excluded. 
Furthermore, we defined a type 1 diabetes subgroup (“type 1 subgroup”) including individuals, who solely claimed 
prescriptions of insulin (ATC A10A) during the study period. 
4.3 Definition of family relations
Family relations were identified using the The Danish Medical Birth Registry, which lists all individuals born in 
Denmark, including the identity of the father and/or mother, if known. Population groups of interest were identified 
as follows: a) any family member has diabetes (second degree relatives being the most remote member identified 
from registries), b) father has diabetes, c) mother has diabetes, d) both parents have diabetes, e) half-sibling 
(common father) has diabetes, f) half-sibling (common mother) has diabetes, g) full sibling has diabetes, h) wife has 
diabetes, and i) husband has diabetes (wife and husband were defined by having a common child).
4.4 Statistical methods
Individuals were included in the study if they were alive during 1995–2018 and not diagnosed with diabetes prior to 
January 1, 1996. Individuals were followed until death, immigration from Denmark or until 31 December 2018. For 
the time dependent analyses, individuals were split first by individual diabetes diagnosis date, then by diagnosis date 
of family relation (mother, father, sibling etc.) resulting in dichotomous variables for each risk profile, and finally by 
age and calendar time both in five-year intervals. 
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Rate ratios (RR) of diabetes incidence and associated p-values were calculated using Poisson regression models that 
included, age, calendar time and familial diabetes by mother, father, half- and full-siblings
The rate (prevalence) of diabetes in the total population was calculated and stratified by year, age, and sex. Likewise, 
the rate of diabetes was calculated for each sub-population of interest, e.g. children with mothers/fathers with 
diabetes, half- and full-siblings etc. 
Results were reported as total population at risk, population diagnosed, percent diagnosed, RR with 95% confidence 
interval (95% CI) as well as p-values were reported. A p-value of less than 0.05 were considered significant.
To evaluate the model assumption of constant risk in time intervals, we examined individuals in one-year intervals of 
age, instead of the original five-year intervals.  No overall difference in incidence rate ratios were observed.
All statistical analyses were carried out using SAS version 9.4 (SAS Institute Cary, North Carolina, USA).
4.5 Ethical considerations
Registry based studies does not require ethical approval in Denmark. The project was approved by the Danish Data 
Protection Agency, approval no. P-2019-382.
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5 Results
In total, 10,052,539 individuals were identified from the Danish registries in the period 1995–2018 and considered 
eligible for inclusion in the study. Of these, 2,759,704 were excluded due to immigration, death prior to inclusion (1 
January 1996), or incomplete data, resulting in a total study population of 7,292,835 individuals. Of these, a total of 
343,237(4.7%) were diagnosed with diabetes (1996-2018). The selection of the study population is illustrated in 
Figure 1.
Baseline demographics are displayed in Table 1. The mean age at diabetes onset was 59.4 years with 90% of 
individuals between 28.0 and  78.9 years, and no significant difference was observed between males (N= 175,894) 
and females (N= 167,373). 
The Birth Registry contained data on  4,423,476 childbirths, of which  4,070,681 ( 92,0 %) had data on both parents, 
24,423 (0.6%) had data on the father only, and  328,372 ( 7,4%) on the mother only. 
5.1 Risk of diabetes onset
The multivariable Poisson regression analyses were adjusted for calendar time in periods of five years, age, and sex 
and are presented in Figure 1.
Considering diabetes status, a total of   619,746 (8.5% of all) were at risk for diabetes based on any family member 
with diabetes, of which  36,858 (5.9%) were diagnosed with diabetes during the study period (RR 2.02; p<0.0001). 
For individuals with a diabetic father,  5.1% out of   297,441 at-risk individuals developed diabetes (RR  1,79; 
p<0.0001), for individuals with a diabetic mother,  6.3% out of  250,140 at-risk individuals developed diabetes (RR  
2.06; p<0.0001), and 9.6% out of  33,224 at-risk individuals with both parents being diabetic developed diabetes 
during the study period (RR  3,40; p<0.0001). The risk of developing diabetes was significantly higher for maternal as 
compared to paternal relation (p<0.0001).
Of  99,600 individuals with a diabetic wife, 14.4% developed diabetes (RR  1.60; p<0.0001), whereas only 10.5% of  
140,071 individuals with a diabetic husband developed diabetes during the study period (RR  1.41; p<0.0001).
Of  121,357 full siblings at risk,  11.1% developed diabetes (RR  2.77; p<0.0001), whereas only  5.4% and 6.6% of half-
siblings with a common father or mother, respectively, developed diabetes (RR  1.99 and  2.35; p<0.0001). For twins,  
21.2% out of  1,704 at-risk developed diabetes (RR  5.76; p<0.0001). It was not possible to distinguish identical and 
fraternal twins from the Registries.
All analyses were repeated in the type 1 subgroup (Figure 3), which included  23,054 individuals (0.3%). All 
population groups were found to be associated with a statistically significant elevated risk of diabetes. 
In the type 1 subgroup, the greatest risk was observed among individuals with a diabetic twin (RR  39.77; p<0.0001), 
followed by individuals with both parents being diabetic (note that only 3 individuals were included in this group; RR  
9.33; p=0.026), individuals with a diabetic sibling (RR 10.56; p<0.001), a diabetic mother (RR  4.48; p<0.0001) or 
father (RR  3.23; p<0.0001).
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A subgroup analysis of males and females at risk of developing diabetes based on one or more diabetic parents were 
performed. For females with a diabetic mother was 1.97 (95% CI: 1.92–2.02; p<0.0001), a diabetic father 1.74 (95% 
CI: 1.70–1.79; p<0.0001) and if both were diabetic 3.24 (95% CI: 3.05–3.45; p<0.0001). Similarly for males the RR was 
2.19 (95% CI: 2.12–2.25; p<0.0001) 1.85 (95% CI: 1.80–1.91; p<0.0001) and 3.61 (95% CI: 3.37–3.88; p<0.0001). See 
also Figure 4.
The subgroup analysis was further expanded by including an analysis of males and females with a parent >60 years 
of age at diabetes onset. The RR for males with fathers (>60) were 1.58, and for males with mothers (>60) RR was 
1.71. Similarly for females with fathers (>60) RR was 1.62 and for females with mothers (>60) RR was 1.77.
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6 Discussion
In this nationwide study we examined the risk of developing diabetes in offspring and spouses of more than 300,000 
individuals with diabetes, we demonstrate a strong familial clustering regarding both genetic as well as non-genetic 
(second degree relatives and spouses) relations. Hence, our findings suggest that both genetic and environmental 
factors have predictive value regarding the risk of developing diabetes. Surprisingly, the results were consistent in a 
subgroup of individuals with type 1 diabetes, although with lower statistical significance, owing to the smaller 
sample size ( 23,054 in the type1 group vs.  343,237 in the any diabetes group).
Overall, the risk of developing diabetes increased with the number of family members with diabetes; the strongest 
risk was associated with children, where both parents had diabetes, as well as twins with a diabetic sibling. 
Similarly, the risk increased for individuals with a genetically unrelated family member with diabetes, such as a 
second-degree relatives and spouses. Subgroup analysis of males vs. females, and diabetic parents below/above 60 
years of age showed similar results.
Altogether we believe our findings indicate that both genetic factors play a for the risk of developing diabetes, as 
well as environmental factors, indicated by the associations found in the examined groups of individuals with no 
known common genetic dispositions (spouses, thus environmental factors) and groups with varying degrees of 
common genetic inheritance (half and full siblings as well as twins, thus a combination of environment and genetic 
factors). As environmental factors are included in all of the examined subgroups, a predominant environmental 
influence cannot be completely ruled out, although the higher risk associated with increased common genetic 
inheritance (from half siblings to twins) suggests that genetic risk plays and a role as well (Figure 2).
6.1 Comparison with other studies
Our results are in line with a previous study from Sweden studying familial aggregation which found comparable 
rates of diabetes in relation to full sibling, mothers, and fathers. The study also found an increased rate of diabetes 
among half-siblings and non-related family members, including spouses. However, adoptees did not have an 
increased risk of diabetes in relation to their adopted parents, whereas they had an increased risk in relation to their 
biological parents [17]. Our risk estimates were also comparable to a US study examining the RRs for first-degree 
relatives with type 1 and type 2 diabetes [18]. A Finnish study investigated the risk of diabetes given a family history 
of diabetes, which was associated with a significantly increased hazard ratio of 2.2, further supporting family history 
as a strong predictor of diabetes risk [19]. 
Several studies have identified specific genes associated, or potentially associated, with diabetes[9,20] some of these 
indirectly as risk factors of obesity[21]. 
Meigs et al. demonstrated that known genetic risk factors only had a slightly increased predictive value of diabetes, 
as compared to common non-genetic risk factors [22]. This study is not in conflict with our findings, as Meigs et al. 
focused on known genetic factors. Our data on the other hand, focused on known family relations thus including all 
genetic risk factors, known as well as unknown, in our study which indicated similar overall conclusions.
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Similarly in a recent study by Poveda et al., genetic risk factors and lifestyle risk factors contributed evenly to the risk 
of developing diabetes [23], but again only known genetic risk factors were examined. A similar conclusion was 
reached by Lyssenko et al. [24]. Overall the studies attempting to predict diabetes based on clinical risk factors and 
genetic factors are vulnerable due to the relatively low predictive value of the known genes, which in turn could 
indicate that the genes examined are not the most significant risk factors [25]. It should be noted that Bothe the 
study by Poveda and Meigh only focused on type 2 diabetes.
Our results might be in conflict with a study by Knowler et al. regarding intervention with lifestyle versus metformin 
[26]. In the study by Knowler et al. , the authors demonstrate that lifestyle intervention is a much stronger 
intervention to prevent the onset of diabetes, than metformin treatment, in individuals with elevated fasting 
glucose. However, the study included ‘high-risk’ individuals with high fasting glucose levels, which in turn could 
indicate genetic disposition, whereas our study could be interpreted as genetic factors are predominant in the 
overall risk.
6.2 Strengths and weaknesses of the study
A major strength of the present study is the number of eligible study participants, which are well above six million. 
The Danish National Registries are reliable sources of data [27,28], and due to the number of individuals anyone with 
unreliable or incomplete (missing) data can be readily excluded.
The most obvious bias in this kind of study would be selection bias, e.g. the validity of the data in the registry. Based 
on several other studies[27,29], the Danish National registries are a very valid source of information[14], and 
therefore we consider the selection of individuals as valid. By including the entire population of Denmark, we 
avoided any selection bias related to age, sex, income, willingness to participate, relation to a physician, or health 
insurance organizations.
However, although the National Prescription Registry contains information on all prescribed drugs, the indication for 
the prescription is not available. Consequently, any drug prescribed for a different reason than blood glucose 
lowering due to diabetic status, could lead to a wrong conclusion. However, as the overwhelming majority of glucose 
lowering drugs only is prescribed to diabetic individuals, we consider the risk of miss-diagnosis negligible in the 
current context.
With regards to the definition of type1 vs. type2 diabetes, our definition of type2 based on any other glucose 
lowering drug aside from insulin would qualify as a type2 individual seems robust. However, there may be a small 
number of individuals with type2 diabetes who especially in recent years received insulin only, however generally 
uncommon, which could lead to a misclassification in the type1 group. We have tried to minimize this problem by 
introducing a one year quarantine period in the beginning of  our study period (see also Methods section).
Unfortunately, we did not have access to other important clinical information in risk factor control, such as lipid 
disorders, body mass index, smoking, physical activity, and dietary factors, and consequently we were unable to take 
these measures into account when estimating diabetes risk. 
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The Birth Registry had incomplete information on parental status, as in  4,070,681 ( 55.8%) cases were both parents 
known, whereas in 24,423 (0.3%) cases only the father was known and in  328,372 ( 4.5%) only the mother was 
known and in  2,869,359 ( 39,3%) of cases the registry contained no information on parents. Some insecurity may 
also apply to the registration of the biological father when compared to the mother. Consequently, data of relatives 
are lower than would be expected if data for all  7.3 million individuals were known. 
6.3 Perspectives for future research
Although our data strongly indicate that genetic risk factors account for the majority of the proneness for an 
individual to develop diabetes, further investigation is needed to asses which genes – known or unknown – that 
account for the most important findings. Furthermore, although we claim that the environmental factors are 
secondary, this claim is based on the increased risks observed in second-degree relatives (half-siblings) and choice of 
spouse. This conclusion could be erroneous because we really have no direct measurement of risk factors other than 
the need for diabetic drugs and family relation, thus eating at the same dinner table may lead to obesity for the 
entire family, and this could be interpreted wrongly as a genetic disposition.
Despite the entanglement of genetic, intergenic, environmental factors, and combinations of all of them have 
considerable technical challenges [30], based on our findings, we consider it important to further pursue genetic 
components associated with diabetes.
Future studies should aim to identify genes that in combination with risk factors lead to onset of diabetes.
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Table 1: Demographics of population with onset of diabetes 1996-2012.
Family relation At when first risk (% of all) Diagnosed (%) Age with 95% CI Person years all 
(x100.000)
Person years diagnosed 
(x100.000, % of all)
Total population 7,292,835 (100.0%) 343,237 (4.7%) 59.4 (95% CI: 59.4-59.5) 1,195.72 42.05 (3.5%)
Risk if mother has diabetes 250,140 (3.4%) 15,789 (6.3%) 43.5 (95% CI: 43.3-43.6) 50.89 2.35 (4.6%)
Risk if father has diabetes 297,441 (4.1%) 15,065 (5.1%) 41.5 (95% CI: 41.3-41.7) 62.92 2.24 (3.6%)
Risk if both parents has diabetes 33,224 (0.5%) 3,201 (9.6%) 41.6 (95% CI: 41.3-42.0) 7.01 0.48 (6.9%)
Risk if full sibling has diabetes 121,357 (1.7%) 13,455 (11.1%) 44.7 (95% CI: 44.5-44.9) 25.64 1.91 (7.5%)
Risk if half sibling (common mother) has diabetes 14,881 (0.2%) 983 (6.6%) 40.0 (95% CI: 39.3-40.8) 3.13 0.14 (4.5%)
Risk if half sibling (common father) has diabetes 16,914 (0.2%) 912 (5.4%) 40.1 (95% CI: 39.3-40.9) 3.55 0.13 (3.7%)
Risk if twin has diabetes 1,704 (0.0%) 362 (21.2%) 42.8 (95% CI: 41.2-44.4) 0.34 0.05 (14.9%)
Risk if husband has diabetes 140,071 (1.9%) 14,691 (10.5%) 60.1 (95% CI: 59.9-60.3) 28.11 1.88 (6.7%)
Risk if wife has diabetes 99,600 (1.4%) 14,384 (14.4%) 62.6 (95% CI: 62.5-62.8) 17.87 1.74 (9.7%)
Risk if any familiy member has diabetes 619,746 (8.5%) 36,858 (5.9%) 43.1 (95% CI: 43.0-43.2) 129.03 5.40 (4.2%)
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Eligible for inclusion (1995-2018)
(n=10,052,539)
Excluded (n=2,759,704)
- Immigration, death or diabetes prior 
to study startIncluded for diagnose (at risk)
(n= 7,292,835)
Diagnosed with diabetes
(n= 343,237)
Background population without diabetes
(n= 6,949,598)
Figure 1: Flowchart of selection of study population
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Figure 2: Risk of all types of diabetes dependent on family relation. Note that the percentage of individuals with diabetes may differ from the calculated relative risk (RR). This is due to the fact that risk estimates 
are calculated based on data stratified by age of diabetes onset, sex and calendar year, thus allowing a difference between calculated ”raw” percentages and relative risks.
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Figure 3; Risk of diabetes based on family relation for individuals with type 1 diabetes. See also main paper Figure 2 for explanations of data.
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Figure 4: Scatter plot of diabnose age of person at risk, plotted towards diabetic parent age (if any).
